We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Rubidium 82 cardiac PET has prognostic ...
MONTREAL--(BUSINESS WIRE)--Jubilant DraxImage Inc., (“DraxImage”) www.draximage.com, a wholly Owned Subsidiary of Jubilant Pharma Ltd, announced today that the U.S. Food and Drug Administration has ...
Cardiovascular diagnostic imaging plays a crucial role in modern health care, supporting accurate diagnosis, risk ...
MONTREAL - Jubilant DraxImage Inc., a wholly owned subsidiary of Jubilant Pharma Limited, is pleased to announce the receipt of the CE Mark certificate for its state-of-the-art RUBY Rubidium Elution ...
A new study urges physicians using molecular imaging for the diagnosis of heart disease to use computer data analysis rather than visual interpretation alone. The study shows that when combined, these ...
July 26, 2011 (Rockville, Maryland)— The FDA is now telling physicians to stop using the CardioGen-82 cardiac positron-emission tomography (PET) scanner after issuing an earlier alert about a risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback